Ó¤H¹ï©ó³o¥ó¨Æ±¡, ·P¨ì«D±`¦a¿ò¾Ñ.............
µ§ªÌ»{¬°³o¦¸ªºÖ`¦º®×¨Ò......À³¸Ó¬O.........
¤Z¬O±q¨Æ©Ò¦³¤¤µ¥±j«×¥H¤Wªº¹B°Ê, ³£¦³¥i¯à·|³y¦¨¹B°Ê¤¤©Î¹B°Ê«áªºÖ`¦º®×¨Ò...........
¨Æ¹ê¤W, ACSM¤]¯S§O±j½Õ¤@¯ë¤H¦b¶i¦æ¹B°Ê¤§«e, ¥²¶·°µ¦n°·±dÀˬd, °Ý¨÷½Õ¬d(¨Ò¦pPAR-Q)¥H¤ÎCAD¦MÀI¦]¤lªº§P©w(½Ð°Ñ¦ÒACSM's Guidelines for exercise testing and prescription (6th ed.). 2000.)........
¤¤µ¥·ÀIªÌ¦b°Ñ»P¤¤µ¥±j«×¥H¤Wªº¹B°Ê®É, ¥²¶·¦³Âå®v¦b³õ........
¦]¦¹, ´NÁ|¿ì¹B°ÊÁÉ·|ªºÂå¾Ç¦w¥þºÞ²z¦Ó¨¥, ³Ì¦n¦bÁÉ«e¥Ñ¤j·|´£¨ÑÂå®v¶i¦æªì¨Bªº°·±dÀˬd»P¯e¯f¥v¸ß°Ý, ¦P®É°µ¦n°Ý¨÷ªº½Õ¬d(¥]¬APAR-Q»PCAD risk factor); ·íµM, ÄvÁɤ¤À³³]¸m¨¾Å@¯¸©Î«æ±Ï¯¸, ¨Ã´£¨Ñ¥R¨¬ªº±ÏÅ@¤Hû»P³]³Æ......
·íµM, ³o¨Ç³£¬OºÉ¥i¯à±Æ°£°ª¦MÀI±Ú¸s°Ñ»P¤¤µ¥±j«×¥H¤WªºÄvÁÉ(²¦³ºÄvÁɨ㦳µo´§³Ì¤j§V¤Oªº¯S½è), ¦ý¬O¿©±w¤ßŦ¯e¯fªÌ, ¤]¦³¤£¤Ö¤HÄÝ©óµL¯gª¬ªÌ(asymptomatic)......¦]¦¹, ¥u¯àºÉ¤H¨ÆÅ¥¤Ñ©RÅo!! |